|
[1]LIAO J,HUANG P.Effect of clinical treatment of chronic hepatitis B and correlation analysis[J].China Prac Med,2011,6(31):57-58.(in Chinese)廖炯,黄萍.慢性乙肝的临床治疗效果观察与相关分析[J].中国实用医药,2011,6(31):57-58.
|
|
[2]XIA SL,HE XF.Efficacy of entecavir treatment for patients with chronic hepatitis B[J].J Clin Hepatol,2015,31(4):523-525.(in Chinese)夏淑林,何小峰.恩替卡韦治疗慢性乙型肝炎的疗效观察[J].临床肝胆病杂志,2015,31(4):523-525.
|
|
[3]FAN R,SUN J,HOU JL,et al.Predictors of response and optimized antiviral strategy for patients with chronic hepatitis B[J].J Clin Hepatol,2011,27(12):1239-1244.(in Chinese)樊蓉,孙剑,侯金林,等.慢性乙型肝炎的疗效预测和优化治疗策略[J].临床肝胆病杂志,2011,27(12):1239-1244.
|
|
[4]LI MJ.Clinical analysis of entecavir in initially treating chronic hepatitis B[J].Hebei Med,2010,16(3):293-295.(in Chinese)李敏基.恩替卡韦初治慢性乙肝临床疗效分析[J].河北医学,2010,16(3):293-295.
|
|
[5]CAO ZL.Efficacy of entecavir combined with adefovir dipivoxil in treatment of chronic hepatitis B and its influence on serum levels of interleukin-10 and interferon-γ[J].Shandong Med J,2015,55(13):88-90.(in Chinese)曹智丽.恩替卡韦联合阿德福韦酯治疗慢性乙肝的效果及其对血清IL-10、IFN-γ水平的影响[J].山东医药,2015,55(13):88-90.
|
|
[6]LI SW,ZHANG BL.Albumin and plasma therapy for icteric hepatitis:a clinical analysis[J].Med J Ind Enterp,2003,16(6):20.(in Chinese)李圣伟,张宝莲.白蛋白及血浆治疗黄疸型肝炎的临床观察[J].工企医刊,2003,16(6):20.
|
|
[7]WANG AJ,LIU M.Central venous catheter with fresh plasma treatment refractory cirrhosis ascites[J].Chin J Mod Drug Appl,2013,7(2):23-24.(in Chinese)王爱军,刘茗.中心静脉导管腹腔置管放腹水联合新鲜血浆治疗肝硬化顽固性腹水[J].中国现代药物应用,2013,7(2):23-24.
|
DownLoad: